Page 1990 - Williams Hematology ( PDFDrive )

1964 Part XII: Hemostasis and Thrombosis Chapter 114: Control of Coagulation Reactions 1965

250. Finigan JH, Dudek SM, Singleton PA, et al: Activated protein C mediates novel lung 278. Ndonwi M, Tuley EA, Broze GJ Jr: The Kunitz-3 domain of TFPI-alpha is required
endothelial barrier enhancement: Role of sphingosine 1-phosphate receptor transacti- for protein S-dependent enhancement of factor Xa inhibition. Blood 116(8):1344–1351,
vation. J Biol Chem 280(17):17286–17293, 2005. 2010.
251. Schuepbach RA, Feistritzer C, Fernandez JA, et al: Protection of vascular barrier integ- 279. Hackeng TM, Sere KM, Tans G, Rosing J: Protein S stimulates inhibition of the tissue
rity by activated protein C in murine models depends on protease-activated receptor-1. factor pathway by tissue factor pathway inhibitor. Proc Natl Acad Sci U S A 103(9):
Thromb Haemost 101(4):724–733, 2009. 3106–3111, 2006.
252. Bae JS, Yang L, Rezaie AR: Receptors of the protein C activation and activated protein C 280. Heeb MJ, Prashun D, Griffin JH, Bouma BN: Plasma protein S contains zinc essen-
signaling pathways are colocalized in lipid rafts of endothelial cells. Proc Natl Acad Sci tial for efficient activated protein C-independent anticoagulant activity and binding
U S A 104(8):2867–2872, 2007. to factor Xa, but not for efficient binding to tissue factor pathway inhibitor. FASEB J
253. Russo A, Soh UJ, Paing MM, et al: Caveolae are required for protease-selective signaling 23(7):2244–2253, 2009.
by protease-activated receptor-1. Proc Natl Acad Sci U S A 106(15):6393–6397, 2009. 281. Heeb MJ, Marzec U, Gruber A, Hanson SR: Antithrombotic activity of protein S
254. Mosnier LO, Sinha RK, Burnier L, et al: Biased agonism of protease-activated receptor 1 by infused without activated protein C in a baboon thrombosis model. Thromb Haemost
activated protein C caused by non-canonical cleavage at Arg46. Blood 120(26):5237–5246, 107(4):690–698, 2012.
2012. 282. Dahlback B: Purification of human C4b-binding protein and formation of its complex
255. Scarborough RM, Naughton MA, Teng W, et al: Tethered ligand agonist peptides. with vitamin K-dependent protein S. Biochem J 209(3):847–856, 1983.
Structural requirements for thrombin receptor activation reveal mechanism of proteo- 283. Griffin JH, Gruber A, Fernández JA: Reevaluation of total, free, and bound protein S
lytic unmasking of agonist function. J Biol Chem 267(19):13146–13149, 1992. and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin. Blood
256. Soh UJ, Trejo J: Activated protein C promotes protease-activated receptor-1 cytopro- 79(12):3203–3211, 1992.
tective signaling through beta-arrestin and dishevelled-2 scaffolds. Proc Natl Acad Sci 284. Schwarz HP, Muntean W, Watzke H, et al: Low total protein S antigen but high protein S
U S A 108(50):E1372–E1380, 2011. activity due to decreased C4b-binding protein in neonates. Blood 71(3):562–565, 1988.
257. Burnier L, Mosnier LO: Novel mechanisms for activated protein C cytoprotective 285. Maurissen LF, Thomassen MC, Nicolaes GA, et al: Re-evaluation of the role of the pro-
activities involving non-canonical activation of protease-activated receptor 3. Blood tein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inacti-
122(5):807–816, 2013. vation. Blood 111(6):3034–3041, 2008.
258. Stavenuiter F, Mosnier LO: Non-canonical PAR3 activation by factor Xa identi- 286. Hillarp A, Dahlbäck B: Novel subunit in C4b-binding protein required for protein S
fies a novel pathway for Tie2 activation and stabilization of vascular integrity. Blood binding. J Biol Chem 263(25):12759–12764, 1988.
124(23):3480–3489, 2014. 287. Hillarp A, Hessing M, Dahlback B: Protein S binding in relation to the subunit compo-
259. Yang XV, Banerjee Y, Fernandez JA, et al: Activated protein C ligation of ApoER2 sition of human C4b-binding protein. FEBS Lett 259(1):53–56, 1989.
(LRP8) causes Dab1-dependent signaling in U937 cells. Proc Natl Acad Sci U S A 288. Fernandez JA, Griffin JH: A protein S binding site on C4b-binding protein involves beta
106(1):274–279, 2009. chain residues 31–45. J Biol Chem 269(4):2535–2540, 1994.
260. Xu J, Ji Y, Zhang X, et al: Endogenous activated protein C signaling is critical to pro- 289. Fernández JA, Griffin JH, Chang GT, et al: Involvement of amino acid residues 423–429
tection of mice from lipopolysaccharide induced septic shock. J Thromb Haemost of human protein S in binding to C4b-binding protein. Blood Cells Mol Dis 24(2):101–
7(5):851–856, 2009. 112, 1998.
261. Alabanza LM, Esmon NL, Esmon CT, Bynoe MS: Inhibition of endogenous activated 290. Garcia de Frutos P, Alim RI, Hardig Y, et al: Differential regulation of alpha and beta
protein C attenuates experimental autoimmune encephalomyelitis by inducing mye- chains of C4b-binding protein during acute-phase response resulting in stable plasma
loid-derived suppressor cells. J Immunol 191(7):3764–3777, 2013. levels of free anticoagulant protein S. Blood 84(3):815–822, 1994.
262. Kager LM, Joost WW, Roelofs JJ, et al: Endogenous protein C has a protective role 291. Anderson HA, Maylock CA, Williams JA, et al: Serum-derived protein S binds to phos-
during Gram-negative pneumosepsis (melioidosis). J Thromb Haemost 11(2):282–292, phatidylserine and stimulates the phagocytosis of apoptotic cells. Nat Immunol 4(1):87–
2013. 91, 2003.
263. Heeb MJ, Gruber A, Griffin JH: Identification of divalent metal ion-dependent inhi- 292. Prasad D, Rothlin CV, Burrola P, et al: TAM receptor function in the retinal pigment
bition of activated protein C by alpha 2-macroglobulin and alpha 2-antiplasmin in epithelium. Mol Cell Neurosci 33(1):96–108, 2006.
blood and comparisons to inhibition of factor Xa, thrombin, and plasmin. J Biol Chem 293. Uehara H, Shacter E: Auto-oxidation and oligomerization of protein S on the apoptotic
266(26):17606–17612, 1991. cell surface is required for Mer tyrosine kinase-mediated phagocytosis of apoptotic
264. Heeb MJ, Griffin JH: Physiologic inhibition of human activated protein C by alpha cells. J Immunol 180(4):2522–2530, 2008.
1-antitrypsin. J Biol Chem 263(24):11613–11616, 1988. 294. McColl A, Bournazos S, Franz S, et al: Glucocorticoids induce protein S-dependent
265. Heeb MJ, Espana F, Griffin JH: Inhibition and complexation of activated protein C by phagocytosis of apoptotic neutrophils by human macrophages. J Immunol 183(3):
two major inhibitors in plasma. Blood 73(2):446–454, 1989. 2167–2175, 2009.
266. Espana F, Vicente V, Tabernero D, et al: Determination of plasma protein C inhibi- 295. Liu D, Guo H, Griffin JH, et al: Protein S confers neuronal protection during ischemic/
tor and of two activated protein C-inhibitor complexes in normals and in patients hypoxic injury in mice. Circulation 107(13):1791–1796, 2003.
with intravascular coagulation and thrombotic disease. Thromb Res 59(3):593–608, 296. Fernandez JA, Heeb MJ, Xu X, et al: Species-specific anticoagulant and mitogenic activ-
1990. ities of murine protein S. Haematologica 94(12):1721–1731, 2009.
267. Espana F, Gilabert J, Aznar J, et al: Complexes of activated protein C with alpha 1-anti- 297. Zhu D, Wang Y, Singh I, et al: Protein S controls hypoxic/ischemic blood-brain barrier
trypsin in normal pregnancy and in severe preeclampsia. Am J Obstet Gynecol 164 disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.
(5 Pt 1):1310–1316, 1991. Blood 115(23):4963–4972, 2010.
268. Scully MF, Toh CH, Hoogendoorn H, et al: Activation of protein C and its distribu- 298. Zhong Z, Wang Y, Guo H, et al: Protein S protects neurons from excitotoxic injury
tion between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-mac- by activating the TAM receptor Tyro3-phosphatidylinositol 3-kinase-Akt pathway
roglobulin, in patients with disseminated intravascular coagulation. Thromb Haemost through its sex hormone-binding globulin-like region. J Neurosci 30(46):15521–15534,
69(5):448–453, 1993. 2010.
269. Bhiladvala P, Strandberg K, Stenflo J, Holm J: Early identification of acute myocardial 299. Guo H, Barrett TM, Zhong Z, et al: Protein S blocks the extrinsic apoptotic cascade in
infarction by activated protein C–protein C inhibitor complex. Thromb Res 118(2): tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-F-
213–219, 2006. KHRL1 signaling pathway. Mol Neurodegener 6(1):13, 2011.
270. Schwarz HP, Fischer M, Hopmeier P, et al: Plasma protein S deficiency in familial 300. Gray E, Hogwood J, Mulloy B: The anticoagulant and antithrombotic mechanisms of
thrombotic disease. Blood 64(6):1297–1300, 1984. heparin. Handb Exp Pharmacol (207):43–61, 2012.
271. Comp PC, Nixon RR, Cooper MR, Esmon CT: Familial protein S deficiency is associ- 301. Broze GJ Jr, Girard TJ: Tissue factor pathway inhibitor: Structure-function. Front Biosci
ated with recurrent thrombosis. J Clin Invest 74(6):2082–2088, 1984. (Landmark Ed) 17:262–280, 2012.
272. Stenberg Y, Muranyi A, Steen C, et al: EGF-like module pair 3–4 in vitamin K-depen- 302. Winckers K, ten Cate H, Hackeng TM: The role of tissue factor pathway inhibitor in
dent protein S: Modulation of calcium affinity of module 4 by module 3, and interaction atherosclerosis and arterial thrombosis. Blood Rev 27(3):119–132, 2013.
with factor X. J Mol Biol 293(3):653–665, 1999. 303. Wood JP, Ellery PE, Maroney SA, Mast AE: Biology of tissue factor pathway inhibitor.
273. Yegneswaran S, Hackeng TM, Dawson PE, Griffin JH: The thrombin-sensitive region Blood 123(19):2934–2943, 2014.
of protein S mediates phospholipid-dependent interaction with factor Xa. J Biol Chem 304. Gettins PG: Serpin structure, mechanism, and function. Chem Rev 102(12):4751–4804,
283(48):33046–33052, 2008. 2002.
274. van ‘t Veer C, Hackeng TM, Biesbroeck D, et al: Increased prothrombin activation in 305. Whisstock JC, Bottomley SP: Molecular gymnastics: Serpin structure, folding and mis-
protein S-deficient plasma under flow conditions on endothelial cell matrix: An inde- folding. Curr Opin Struct Biol 16(6):761–768, 2006.
pendent anticoagulant function of protein S in plasma. Blood 85(7):1815–1821, 1995. 306. Rau JC, Beaulieu LM, Huntington JA, Church FC: Serpins in thrombosis, hemostasis
275. Koppelman SJ, Hackeng TM, Sixma JJ, Bouma BN: Inhibition of the intrinsic factor X and fibrinolysis. J Thromb Haemost 5 Suppl 1:102–115, 2007.
activating complex by protein S: Evidence for a specific binding of protein S to factor 307. Huntington JA: Serpin structure, function and dysfunction. J Thromb Haemost 9 (Suppl 1):
VIII. Blood 86:1062–1071, 1995. 26–34, 2011.
276. Koppelman SJ, van ‘t Veer C, Sixma JJ, Bouma BN: Synergistic inhibition of the intrinsic 308. Huntington JA: Thrombin inhibition by the serpins. J Thromb Haemost 11
factor X activation by protein S and C4b-binding protein. Blood 86(7):2653–2660, 1995. (Suppl 1):254–264, 2013.
277. Peraramelli S, Rosing J, Hackeng TM: TFPI-dependent activities of protein S. Thromb 309. Schreuder HA, de Boer B, Dijkema R, et al: The intact and cleaved human antithrombin III
Res 129 Suppl 2:S23–S26, 2012. complex as a model for serpin-proteinase interactions. Nat Struct Biol 1(1):48–54, 1994.

Kaushansky_chapter 114_p1949-1966.indd 1965 9/18/15 10:06 AM